Delivery Order SPE2DB20D1047-SPE2DB25FF86U
- Not listed
- The Defense Logistics Agency awarded a $5,227.66 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (unit dose 10s) on July 23, 2025, with completion targeted for July 24, 2025. This competitively awarded, firm fixed-price contract reflects a routine pharmaceutical procurement through the agency's medical supply chain. The work will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This...
- The Defense Logistics Agency awarded a delivery order valued at $8,959.34 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets in unit dose packages of 10 units. The contract, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, operates under a firm fixed price arrangement with no set-aside designation. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, serves as the performing location for this pharmaceutical supply delivery. This...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of UBRELVY 100 mg tablet unit dose packages (10 count). This competitively awarded, non-set-aside contract carries a ceiling value of $3,712.21 with a firm fixed price structure and an ultimate completion date of August 27, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate office and...
- The Defense Logistics Agency awarded a $2,051.65 delivery order to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (10-count unit dose) on September 8, 2025, with completion scheduled for September 9, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating competitive award. The performance location is AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. As a major pharmaceutical distributor and critical vendor for federal medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging (16 count). The contract, valued at $12,694.80, represents a firm fixed-price delivery order with no set-aside designation, indicating competitive award authority. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion prime vendor...
- The Defense Logistics Agency awarded a delivery order valued at $2,164.44 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (10-count unit dose packaging) on September 19, 2025, with completion expected by September 22, 2025. This competitively awarded, non-set-aside firm fixed price delivery order will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a $3,430.55 delivery order to AmerisourceBergen Drug Corp for UBRELVY 50 mg tablets (10 units) on September 8, 2025, with an ultimate completion date of September 9, 2025. This is a firm fixed-price, non-set-aside contract for pharmaceutical supply to support federal medical procurement needs. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for military and...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 9, 2025, for the supply of UBRELVY 100 mg tablets in unit-dose packaging (10 tablets per package). This is a firm fixed-price delivery order valued at $9,494.44, with an ultimate completion date of September 10, 2025. The contract carries no set-aside designation and was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of UBRELVY 100 mg tablets in unit dose packaging (10-count). This competitively awarded, non-set-aside contract carries a ceiling value of $10,509.46 under a firm fixed price arrangement with an ultimate completion date of September 4, 2025. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $18,890.27 to AmerisourceBergen Drug Corp for the supply of UBRELVY 100 mg tablets (10 unit-dose packs). This competitive, firm fixed-price delivery order was awarded on August 14, 2025, with an ultimate completion date of August 15, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. The contract involves no set-aside designation, indicating the award was made through open...
- SPE2DB20D1047Indefinite Delivery Contract
- SPE2DB20D1047-SPE2DB25FF86UDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $8,699.26 to AmerisourceBergen Drug Corp for UBRELVY 100 mg tablets (100 units in unit dose packaging). The contract is a firm fixed price delivery order with an ultimate completion date of September 22, 2025, and was awarded on September 19, 2025 without a set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will fulfill this order from its corporate office location. This delivery order represents a child contract under AmerisourceBergen Drug Corp's significant Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The SPE2DX contract serves as a comprehensive global pharmaceutical support vehicle enabling AmerisourceBergen Drug Corp to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The parent contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains. Through this vehicle, the company serves federal healthcare customers including the Defense Health Agency and U.S. Coast Guard. The competitively awarded IDC demonstrates AmerisourceBergen Drug Corp's capability to meet federal procurement requirements and positions the company as a critical vendor for military and veteran healthcare systems within the DLA's medical supply chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.7k | 9/19/25 |